IPV 백신 시장 : 백신 브랜드별, 유통 채널별, 지역별, 규모, 점유율, 전망 및 기회 분석(2025-2032년)

Ipv Vaccines Market is estimated to be valued at USD 217.7 Mn in 2026 and is expected to reach USD 395.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at USD 217.7 Mn in 2026 and is expected to increase to US$ 395.4 Mn by 2033, registering a CAGR of 8.9% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2020, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market

Detailed Segmentation:

• Global IPV Vaccines Market, by Vaccine Brand (Revenue, USD Mn, 2021 - 2033)
• Poliovac (Pfs/Sd)
• Shanipv
• Poliorix
• Ipol/Imovax
• Polymilex
• Global IPV Vaccines Market, by Distribution Channel (Revenue, USD Mn, 2021 - 2033)
• Private
• Public
• Global IPV Vaccines Market, by Region (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles:
• GlaxoSmithKline Plc*
  • Company highlights
  • Product Portfolio
  • Key Highlights
  • Financial performance
  • Strategies
• Sanofi S.A.
• Serum Institute of India Pvt. Ltd.
• PT Bio Farma
• AJ Vaccines

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Brand
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Vial Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Market Scenario - Conservative, Likely, Opportunistic
• Market Opportunity Map

3. Key Insights

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Pest Analysis
• Porters Analysis
• Company Market Share Analysis
• Import-Export Analysis
• Regulatory Scenario
• Pricing Analysis
• Epidemiology
• Healthcare Spending, by Country
• Vaccination Rate, by Country
• Manufacturing Capacities
• Distributors Landscape
• Investments & Funding
• Competitive Snapshot
• Heat Map Analysis

4. Global IPV Vaccines Market, By Vaccine Brand, 2021 - 2033 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033
  • Market Y-o-Y Growth Comparison (%), 2021 - 2033
  • Segment Trends
• POLIOVAC (PFS/SD), 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)
• SHANIPV, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)
• POLIORIX, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)
• IPOL/IMOVAX, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)
• POLYMILEX, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)

5. Global IPV Vaccines Market, By Vaccine Type, 2021 - 2033 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033
  • Market Y-o-Y Growth Comparison (%), 2021 - 2033
  • Segment Trends
• Combination Vaccine, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)
• Single Vaccine, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)

6. Global IPV Vaccines Market, By Vial Type, 2021 - 2033 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033
  • Market Y-o-Y Growth Comparison (%), 2021 - 2033
  • Segment Trends
• 1 Dose Vial, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)
• 5 Dose Vial, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)
• 10 Dose Vial, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)

7. Global IPV Vaccines Market, By Distribution Channel, 2021 - 2033 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033
  • Market Y-o-Y Growth Comparison (%), 2021 - 2033
  • Segment Trends
• Public, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)
• Private, 2021 - 2033(US$ Million)
  • Introduction
  • Market Size and Forecast, 2021 - 2033, (US$ Million)

8. Global IPV Vaccines Market, By Region, 2021 - 2033 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, (US$ Million)
  • Market Y-o-Y Growth Comparison (%), 2021 - 2033, (US$ Million)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest Of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Asean
    • Rest Of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
    • GCC
    • Israel
    • Rest Of The Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, (US$ Million)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Competitive Snapshot
• What Market Participants are Saying?
• Competitive Dashboard
• Company Market Share Analysis, 2026 - Global

10. Company Profiles - Global IPV Vaccines Market

• Sanofi*
  • Company Overview
  • Product/Service Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategic Overview
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech
• Merck & Co., Inc.
• GlaxoSmithKline
• AJ Vaccines A/S
• Panacea Biotec
• Biken
• Sinopharm Group Co. Ltd.
• Nanolek
• IMBCAMS
• Sinovac Biotech
• LG Chem
• Beijing Minhai Biological Technology Co., Ltd.
• Biological E Limited.
• Section 10: Wheel of Fortune
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact